A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy.
about
Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorderTricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescentsContemporary assessment and pharmacotherapy of Tourette syndromeUsing Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in YouthsPharmacotherapy of aggression in children and adolescents: efficacy and effect sizeComparing the efficacy of medications for ADHD using meta-analysisPharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveatsAttention-deficit hyperactivity disorder (ADHD).A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorderNon-stimulant treatments for ADHD.Non-stimulant treatment for attention deficit hyperactivity disorder.New developments in psychopharmacology of attention deficit hyperactivity disorder.Medication strategies in childhood aggression: a review.A new paradigm for developing drugs in children: atomoxetine as a model.The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.Attention-deficit/hyperactivity disorder: using P300 topography to choose optimal treatment.Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial.Dopamine vs noradrenaline: inverted-U effects and ADHD theories.Pharmacology and pharmacogenetics of pediatric ADHD with associated aggression: a review.Pharmacotherapy of attention-deficit hyperactivity disorder.Clinical management of Tourette's syndrome and associated disorders.The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex.Trimipraminium maleate.Duloxetine may improve some symptoms of attention-deficit/hyperactivity disorder.Panax ginseng may improve some symptoms of attention-deficit hyperactivity disorder.A placebo-controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.Development and Qualification of Physiologically Based Pharmacokinetic Models for Drugs With Atypical Distribution Behavior: A Desipramine Case Study.The promise and challenges of drug repurposing in psychiatry.
P2860
Q22252504-71EFC943-1715-4E49-B15C-3A9F39884D98Q24193517-9FB802A2-D778-446E-9701-5AA8D9886CA6Q24607941-447E84EF-8C83-41A1-9289-5B70A6366CFBQ24642024-14F38F69-9F3D-4D40-AF72-D7D69FE9A373Q24648097-2468D496-DB75-48D4-9312-EDC9F385A922Q24685027-463FFBB4-F28E-47B1-B130-4C689DAB1B00Q28138163-2880EFCE-219F-4A8E-A6B0-C808BBC52555Q30976949-FBB916AE-6BFC-4128-B166-04C7DD406327Q34041736-E38332FB-975A-445B-88E3-3E6D50093B8DQ34120068-C5E652E6-3309-4712-9FB1-00DA1AC83FCDQ34396669-AD00FF7F-CB34-4F16-A564-04B9C61D3814Q34481761-27373678-F0CC-4C69-BE37-F738862389F9Q35190427-28D1F9B1-B5B7-4011-A8B3-7E31C272BAABQ36017525-1524240C-543A-4992-B36A-E4F74449A13BQ36082025-E9A59DB1-EBD8-4115-9595-2BC48325F4AAQ36641490-1C1063B2-8989-4836-BB38-1849319C43B1Q36703814-54E40910-0F8E-4F74-9766-52E1C49780F2Q37372629-F8B3D6F3-3317-477A-9A77-EFD4817B325CQ38084902-D8B24EF4-D789-4A64-AA36-9B1AFC717CBCQ40713183-A06BEC35-F67E-4952-81D3-B6B98A742393Q41016123-43020F63-FA06-4E37-8756-4C3E44F9CC26Q41570471-6BC73599-F800-433D-A43D-2FBADF643879Q42044594-6A59A58D-0475-4137-B5D3-A32F21E786A2Q42686386-F88E97DD-E98A-47CF-A421-0F98513A6D59Q42720342-0BA8D8F6-63F2-4DDC-9895-10384031E3A7Q44393742-C498CC2F-062B-444E-95F8-DC7797B4D9A2Q46018689-39DCCB6D-ACA1-4097-9C8C-30FA7D108C26Q49598397-53DD8F16-C077-42D9-AC91-BB22033F3BD6
P2860
A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy.
description
1989 nî lūn-bûn
@nan
1989 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
A double-blind placebo control ...... treatment of ADD: I. Efficacy.
@ast
A double-blind placebo control ...... treatment of ADD: I. Efficacy.
@en
A double-blind placebo control ...... treatment of ADD: I. Efficacy.
@nl
type
label
A double-blind placebo control ...... treatment of ADD: I. Efficacy.
@ast
A double-blind placebo control ...... treatment of ADD: I. Efficacy.
@en
A double-blind placebo control ...... treatment of ADD: I. Efficacy.
@nl
prefLabel
A double-blind placebo control ...... treatment of ADD: I. Efficacy.
@ast
A double-blind placebo control ...... treatment of ADD: I. Efficacy.
@en
A double-blind placebo control ...... treatment of ADD: I. Efficacy.
@nl
P2093
P1476
A double-blind placebo control ...... treatment of ADD: I. Efficacy.
@en
P2093
Baldessarini RJ
Biederman J
Harmatz JS
P304
P356
10.1097/00004583-198909000-00022
P577
1989-09-01T00:00:00Z